Tetra Bio-Pharma (TBPMF) Gross Margin
Tetra Bio-Pharma (TBPMF) currently has a gross margin of 33.7%. The company is a Biotech cannabis company trading on the OTC.
Current Gross Margin
33.7%
Margin Trend
—
Latest Quarter Margin
—
Quarterly Gross Margin
No margin data available for TBPMF.
Frequently Asked Questions
What is TBPMF's current gross margin?+
Gross margin for Tetra Bio-Pharma is calculated as (revenue minus cost of revenue) divided by revenue, expressed as a percentage. It measures how efficiently the company converts sales into gross profit before operating expenses. Higher margins indicate better pricing power or lower production costs.
What is a good gross margin for cannabis companies?+
Cannabis gross margins vary widely by sub-sector. Retailers typically see 40-55%, vertically integrated MSOs 45-60%, and LPs 20-45%. Tetra Bio-Pharma's margin should be compared to peers in the same sub-sector for meaningful context. Margins above 50% generally indicate strong pricing power.
Why do TBPMF's margins change quarter to quarter?+
Gross margin fluctuations for Tetra Bio-Pharma can result from changes in product mix, pricing pressure from competition, input cost changes (e.g., energy, labor), inventory write-downs, or scaling into new markets where initial costs are higher. Seasonal harvest patterns can also affect margins for cultivators.